{
    "company_name": "Odyssey Gold Limited",
    "file_name": "0c0faea14d108e1617f2d6d2a7c1aae04eb88fe0",
    "data_points": [
        {
            "company_name": "Odyssey Gold Limited",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                4,
                5
            ]
        },
        {
            "company_name": "Odyssey Gold Limited",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                4,
                5
            ]
        },
        {
            "company_name": "Odyssey Gold Limited",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase III",
            "metric_src_pdf_page": [
                4,
                5
            ]
        },
        {
            "company_name": "Odyssey Gold Limited",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                4,
                5
            ]
        },
        {
            "company_name": "Odyssey Gold Limited",
            "industry": "Pharmaceuticals",
            "metric_type": "Inventory of active pharmaceutical ingredients",
            "metric_src_pdf_page": [
                4,
                5
            ]
        }
    ],
    "events": [
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                3,
                4,
                5
            ]
        }
    ]
}